Enzo Health offers an AI-native platform built for home health that automates the patient workflow from referral to reimbursement, connecting front office, clinical, and back office operations in one system. Key product components described include Enzo Intake (referral intake, document conversion, eligibility checks), Enzo Scribe (OASIS validation and AI-assisted documentation during visits), and Enzo QA (continuous chart review for clinical and regulatory accuracy). The company says its platform reduces administrative burden, improves margins, and returns time to clinicians. Enzo launched in 2024 and reports revenue growth of more than 40x in the prior twelve months and adoption by organizations supporting over 500,000 patients annually. With the Series A proceeds, Enzo plans to extend the platform into skilled nursing and hospice to address those settings’ specific workflows and regulatory needs.

Total raised

$20M

Funding rounds

1

Latest round

Series A

Latest activity

May 2026